Jeff Yass’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Jeff Yass’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-48,392	Closed	-$919	–	13734
2023 Q1	$919	Buy	+48,392	New	+$4.66K	﹤0.01%	12422
2022 Q3	–	Sell	-11,725	Closed	-$1K	–	14535
2022 Q2	$1K	Buy	+11,725	New	+$5.79K	﹤0.01%	12740
2021 Q4	–	Sell	-12,305	Closed	-$12K	–	14234
2021 Q3	$12K	Buy	+12,305	New	+$12.8K	﹤0.01%	12597

Other funds holding PEARW

Advisory Research Chicago, Illinois $1B AUM 50.12% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

Jeff Yass's PEARW Position: Q2 2023 in Review

Jeff Yass sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 48,392 shares — an estimated $919 sold.

Jeff Yass first reported a position in PEARW in Q3 2021 and held it in 3 quarters. The position peaked at $12K in Q3 2021. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Jeff Yass reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Jeff Yass sold 48,392 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $919.
Jeff Yass first reported a position in Pear Therapeutics, Inc. Warrant in Q3 2021 and held it in 3 quarters.
Jeff Yass's Pear Therapeutics, Inc. Warrant position peaked at $12K in Q3 2021.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.